Total bilirubin measures the pigment released when red blood cells are broken down and processed by the liver, counting both the fraction already conjugated in the liver and the fraction still bound to albumin in the blood. It speaks for two things at once: the pace of red cell turnover and the liver's ability to take up, conjugate and excrete what that turnover produces. It is a core liver panel marker and also the substance that colours the skin and sclera in jaundice.
No readings for this marker yet.
Raised values most often follow accelerated red cell breakdown, an inherited variation in the conjugating enzyme such as Gilbert's syndrome, liver cell injury of any origin, or obstruction of bile flow. Which of these is in play is usually decided not by the total but by the split between the direct and indirect fractions. Low values carry little clinical weight and are not generally pursued. A single result outside the range is a reason to repeat the test and bring it to a doctor, not a conclusion in itself.
Fasting, a period of poor appetite, intense exercise, an intercurrent infection or lack of sleep can all lift the figure modestly, which matters most in people with Gilbert's syndrome; haemolysis in the tube and prolonged light exposure of the sample distort it in either direction. It is interpreted alongside direct bilirubin, which separates the fractions, and alongside ALT, AST, GGT and alkaline phosphatase, which distinguish liver cell injury from cholestasis. Certain drugs, including paracetamol, nimesulide, ceftriaxone and ursodeoxycholic acid, are a reason to watch it over time.
Reference ranges are general adult values and depend on lab, assay, age and sex. For orientation, not diagnosis — discuss results with your doctor.